What does an LDL cholesterol of 4.33 mmol/L, HDL cholesterol of 1.17 mmol/L, and lipoprotein(a) <10 mg/dL indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lipid Panel Interpretation

Your lipid panel shows significantly elevated LDL cholesterol at 4.33 mmol/L (167 mg/dL), borderline low HDL cholesterol at 1.17 mmol/L (45 mg/dL), and reassuringly low lipoprotein(a) at <10 mg/dL—this profile indicates increased cardiovascular risk requiring intervention.

What These Numbers Mean

LDL Cholesterol: 4.33 mmol/L (167 mg/dL) - ELEVATED

Your LDL cholesterol is substantially above target levels. According to current guidelines:

  • Target LDL for most adults should be <2.6 mmol/L (100 mg/dL) 1, 2
  • For very high-risk individuals (those with established cardiovascular disease or diabetes), the target is even lower at <1.8 mmol/L (70 mg/dL) 1
  • Your level of 4.33 mmol/L places you at significantly increased cardiovascular risk

The clinical significance: Every 1% increase in LDL cholesterol is associated with slightly more than a 2% increase in coronary artery disease risk over 6 years 3. At your current level, you are well above the threshold where pharmacological therapy (statin medication) should be considered alongside lifestyle modifications 4, 1.

HDL Cholesterol: 1.17 mmol/L (45 mg/dL) - BORDERLINE LOW

Your HDL cholesterol is just above the minimum threshold but not optimal:

  • Target HDL should be >1.0 mmol/L (40 mg/dL) for men and >1.2 mmol/L (45-50 mg/dL) for women 4, 5, 6
  • HDL cholesterol <1.0 mmol/L (40 mg/dL) in men and <1.2 mmol/L (45 mg/dL) in women is considered a marker of increased cardiovascular risk 6

The clinical significance: Every 1% decrease in HDL is associated with a 3-4% increase in coronary artery disease risk 3. Low HDL is an independent risk factor that can rival high LDL cholesterol in predicting heart disease 6. Your borderline level suggests room for improvement through lifestyle modifications.

Lipoprotein(a): <10 mg/dL - FAVORABLE

This is the one positive finding in your lipid panel:

  • Elevated Lp(a) is generally defined as >50 mg/dL (≈125 nmol/L) 1, 7
  • Your level of <10 mg/dL is well within the favorable range
  • The 2026 guidelines recommend measuring Lp(a) at least once in a lifetime for risk assessment 8, 9

The clinical significance: Elevated Lp(a) is an independent risk factor for cardiovascular disease that adds to LDL-mediated risk 7, 10. Your low Lp(a) means you do NOT have this additional genetic risk factor, which is reassuring. However, this does not offset your elevated LDL cholesterol risk 7.

Your Cardiovascular Risk Status

Based on your lipid profile alone, you fall into a category requiring intervention:

  • Your LDL of 167 mg/dL exceeds the threshold (130 mg/dL) where drug therapy should be considered 4, 11, 2
  • If you have additional risk factors (age >40-45 for men/>55 for women, smoking, hypertension, family history of premature heart disease, or diabetes), you are at even higher risk and require more aggressive treatment 5, 2

Recommended Actions

Immediate Steps:

  1. Lifestyle modifications (should begin immediately):

    • Reduce saturated fat intake to <7% of total calories
    • Limit cholesterol intake to <200 mg/day
    • Increase physical activity
    • Achieve/maintain healthy weight
    • Stop smoking if applicable 4, 11
  2. Statin therapy should be strongly considered, particularly if:

    • You are over age 40 4, 5
    • You have any additional cardiovascular risk factors 5, 2
    • You have diabetes (which is considered equivalent to having established heart disease) 4, 5
    • Statins are the first-line pharmacological therapy for LDL lowering 4, 12, 1
  3. Target goals with treatment:

    • Primary goal: LDL <2.6 mmol/L (100 mg/dL) 4, 1, 11
    • If you have diabetes or established cardiovascular disease: LDL <1.8 mmol/L (70 mg/dL) 1
    • Secondary goal: HDL >1.0-1.2 mmol/L (40-45 mg/dL depending on sex) 4, 5

Follow-up:

  • Lipid panel should be rechecked annually, or more frequently if treatment is initiated 4, 11
  • If lifestyle modifications alone are attempted, reassess in 3-6 months 11
  • However, given your LDL level of 167 mg/dL, waiting 3-6 months for lifestyle changes alone is not recommended—pharmacological therapy should be initiated concurrently 4

Critical Context

Your low Lp(a) is favorable, but it does not eliminate your cardiovascular risk from elevated LDL cholesterol. Recent evidence demonstrates that LDL-C and Lp(a) contribute independently and additively to cardiovascular risk 7. Even with optimal Lp(a) levels, your elevated LDL requires treatment to reduce your risk of heart attack, stroke, and other cardiovascular events.

References

Guideline

standards of medical care in diabetes.

Diabetes Care, 2004

Related Questions

With an elevated lipoprotein(a) of 200 mg/dL, controlled blood pressure, normal weight, and controlled cholesterol, what additional measures can I take to reduce cardiovascular risk?
In a 70-year-old patient, how frequently should a lipid panel be monitored?
What is the recommended management for a 31-year-old patient with total cholesterol 235 mg/dL, LDL cholesterol 158 mg/dL, a history of hypertension, no diabetes, and who does not smoke?
What is the appropriate management for a 34‑year‑old woman with total cholesterol 221 mg/dL, LDL‑C 121 mg/dL, and HDL‑C 83 mg/dL?
What is the recommended management for a 35‑year‑old patient with BMI (body mass index) 32, family history of premature cardiovascular disease, blood pressure 138/88 mmHg, total cholesterol 232 mg/dL, LDL (low‑density lipoprotein) 125 mg/dL, HDL (high‑density lipoprotein) 34 mg/dL, triglycerides 342 mg/dL, and normal creatinine (renal function) and hemoglobin A1c (glycated hemoglobin)?
What type of ocular injury can lead to a macular pucker?
What is the appropriate meropenem dosing regimen for adults and pediatric patients, including adjustments for renal impairment?
For a patient with an indwelling Foley catheter, when should the catheter be removed before discharge, what follow‑up schedule is recommended if it must remain in place, and what catheter‑care instructions and alternatives should be provided?
How long does it take for blood pressure to stabilize after reducing lisinopril from 20 mg to 10 mg daily?
What is the target free T4 level in central hypothyroidism during pregnancy?
Can scleral compression performed during a retinal examination cause macular puckering?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.